| 产品名称: | SVAM191 EC-SVAM191 |
|---|---|
| 商品货号: | TS192053 |
| Designations: | SVAM191 EC-SVAM191 |
| Species: | Hepatitis B virus, Hepatitis B virus |
| Depositors: | Scripps Clinic and Research Foundation |
| Applications: | SVAM191 available as ATCC 39631 and 40103. This material is cited in a U.S. and/or other Patent and may not be used to infringe the patent claims. |
| Vector: | Construct size (kb): 10.39999961853027 |
| Insert: | DNA: genomic Insert lengths(kb): 1.850000023841858 Gene product: X antigen; X gene product cAg |
| Insert Size (kb): | 1.850 |
| Biosafety Level: | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Comments: | Restriction digests of the clone give the following sizes (kb): BamHI--8.6, 1.85; HindIII--7.4, 1.2, 1.1, 0.6; EcoRI--10.4. SVAM191 available as ATCC 39631 and 40103. This material is cited in a U.S. and/or other Patent and may not be used to infringe the patent claims. Molecular clone of hepatitis BamHI restriction fragment SVAM191 available as ATCC 39631 and 40103. EC-AM1 (ATCC 39629) and SVAM191 (TS192053, 39631) contain the same BamHI fragment of hepatitis B virus. The insert extends from the BamHI site at 1400 of the hepatitis B virus map to the BamHI site at 28. Distributed in aliquots of 100 ng dried. |
| Classification: | Hepadnaviridae, Orthohepadnavirus |
| References: | Moriarty AM. SV40 expression vector containing HBxAg as an expression marker. US Patent 4,942,125 dated Jul 17 1990 |
| Disclosure: | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |